SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022

Nov 8 2022
Sustainable growth momentum evident despite foreign exchange headwinds BOSTON and LAUSANNE, Switzerland, Nov. 08, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today reported financial results for the third quarter ended

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Sales Executive / Senior Sales Executive United Kingdom Clinical Sales
Strategic Account Manager - JAPAN Japan Clinical Sales
BioPharma Business Development Expert / Manager Switzerland BioPharma Sales
Junior Sales Operations Specialist Intern France Clinical Sales
Junior Bioinformation Intern - Tertiary Analysis Switzerland Data Science